These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 16138263

  • 21. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T.
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [Abstract] [Full Text] [Related]

  • 22. Effects of angiotensin receptor blockers on ambulatory plasma Renin activity in healthy, normal subjects during unrestricted sodium intake.
    Jones MR, Sealey JE, Laragh JH.
    Am J Hypertens; 2007 Aug; 20(8):907-16. PubMed ID: 17679042
    [Abstract] [Full Text] [Related]

  • 23. Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
    Morawietz H, Erbs S, Holtz J, Schubert A, Krekler M, Goettsch W, Kuss O, Adams V, Lenk K, Mohr FW, Schuler G, Hambrecht R.
    Circulation; 2006 Jul 04; 114(1 Suppl):I296-301. PubMed ID: 16820589
    [Abstract] [Full Text] [Related]

  • 24. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat.
    Lou M, Blume A, Zhao Y, Gohlke P, Deuschl G, Herdegen T, Culman J.
    J Cereb Blood Flow Metab; 2004 May 04; 24(5):536-47. PubMed ID: 15129186
    [Abstract] [Full Text] [Related]

  • 25. Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders.
    Maeda A, Tamura K, Wakui H, Ohsawa M, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Kanaoka T, Dejima T, Ohki K, Haku S, Yamashita A, Umemura S.
    Int J Med Sci; 2014 May 04; 11(6):646-51. PubMed ID: 24834011
    [Abstract] [Full Text] [Related]

  • 26. Treatment with AT(1) receptor blocker restores diabetes-induced alterations in intracellular Ca(2+) transients and contractile function of rat myocardium.
    Ozdemir S, Ugur M, Gürdal H, Turan B.
    Arch Biochem Biophys; 2005 Mar 01; 435(1):166-74. PubMed ID: 15680918
    [Abstract] [Full Text] [Related]

  • 27. Cardiovascular and electrocardiographic parameters after tonin administration in Wistar rats.
    Damasceno DD, Lima MP, Motta DF, Ferreira AJ, Quintão-Junior JF, Drummond LR, Natali AJ, Almeida AP, Pesquero JL.
    Regul Pept; 2013 Feb 10; 181():30-6. PubMed ID: 23318501
    [Abstract] [Full Text] [Related]

  • 28. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy.
    Jiang QJ, Xu G, Mao FF, Zhu YF.
    J Zhejiang Univ Sci B; 2006 Mar 10; 7(3):228-34. PubMed ID: 16502511
    [Abstract] [Full Text] [Related]

  • 29. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system.
    Araujo AS, Diniz GP, Seibel FE, Branchini G, Ribeiro MF, Brum IS, Khaper N, Barreto-Chaves ML, Belló-Klein A.
    Mol Cell Endocrinol; 2011 Feb 10; 333(1):78-84. PubMed ID: 21168472
    [Abstract] [Full Text] [Related]

  • 30. Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women.
    Mirza FS, Ong P, Collins P, Okamura K, Gerhard-Herman M, Williams GH, Seely EW.
    Menopause; 2008 Feb 10; 15(1):44-50. PubMed ID: 18182939
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin II type 1 receptor blockade abolishes specific K(ATP)channel gene expression in rats with myocardial ischemia.
    Akao M, Sakurai T, Horie M, Otani H, Takano M, Kouchi I, Murakami T, Sasayama S.
    J Mol Cell Cardiol; 2000 Dec 10; 32(12):2239-47. PubMed ID: 11112999
    [Abstract] [Full Text] [Related]

  • 32. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A, Blanc J, Elghozi JL.
    Arch Mal Coeur Vaiss; 2000 Aug 10; 93(8):905-10. PubMed ID: 10989728
    [Abstract] [Full Text] [Related]

  • 33. AT1-receptor antagonism in hypertension: what has been learned with irbesartan?
    Waeber B, Burnier M.
    Expert Rev Cardiovasc Ther; 2003 May 10; 1(1):23-33. PubMed ID: 15030294
    [Abstract] [Full Text] [Related]

  • 34. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
    Lange SA, Wolf B, Schober K, Wunderlich C, Marquetant R, Weinbrenner C, Strasser RH.
    J Cardiovasc Pharmacol; 2007 Jan 10; 49(1):46-55. PubMed ID: 17261963
    [Abstract] [Full Text] [Related]

  • 35. Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning.
    Pantos CI, Malliopoulou VA, Mourouzis IS, Karamanoli EP, Paizis IA, Steimberg N, Varonos DD, Cokkinos DV.
    Thyroid; 2002 Apr 10; 12(4):325-9. PubMed ID: 12034058
    [Abstract] [Full Text] [Related]

  • 36. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
    Kano S, Satoh K, Kaneta S, Ichihara K.
    Pharmacology; 2008 Apr 10; 82(1):22-9. PubMed ID: 18434761
    [Abstract] [Full Text] [Related]

  • 37. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation.
    Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA, Barreto-Chaves ML.
    Basic Res Cardiol; 2010 May 10; 105(3):325-35. PubMed ID: 20155476
    [Abstract] [Full Text] [Related]

  • 38. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.
    J Renin Angiotensin Aldosterone Syst; 2002 Sep 10; 3(3):181-7. PubMed ID: 12563569
    [Abstract] [Full Text] [Related]

  • 39. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
    Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, Nishioku T, Dou J, Delgiacco E, Saavedra JM.
    Stroke; 2006 May 10; 37(5):1271-6. PubMed ID: 16601219
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
    Hotta H, Miura T, Miki T, Togashi N, Maeda T, Kim SJ, Tanno M, Yano T, Kuno A, Itoh T, Satoh T, Terashima Y, Ishikawa S, Shimamoto K.
    Circ Res; 2010 Jan 08; 106(1):129-32. PubMed ID: 19910577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.